Music Therapy for Premature Birth
(WOMB Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how music therapy can assist pregnant women at risk of preterm delivery. Researchers aim to determine if listening to music reduces stress, enhances maternal bonding, and possibly extends pregnancy duration. Participants will receive either four music therapy sessions or no music therapy. The trial seeks women admitted to the hospital for high-risk pregnancies, specifically those planning to stay for at least 48 hours and willing to listen to music. As an unphased trial, this study provides a unique opportunity for participants to contribute to innovative research that could improve maternal and fetal health.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that music therapy is safe for antepartum mothers?
Research has shown that music therapy is safe and easy to manage. Studies have found that it can reduce anxiety in pregnant women and improve the birth weight of their babies. One study discovered that music therapy helped infants in intensive care feel less pain and calm down faster. This suggests that music therapy can gently and effectively support both mothers and babies without causing harm. Overall, music therapy is considered a safe and non-invasive treatment option.1234
Why are researchers excited about this trial?
Researchers are excited about music therapy for premature birth because it offers a non-invasive, drug-free approach to support infant development. Unlike traditional treatments that may involve medication or specialized medical equipment, music therapy focuses on the soothing power of sound to potentially improve outcomes for premature infants. This approach aims to enhance brain development and emotional well-being through structured musical sessions, providing a gentle and comforting intervention that could complement existing medical care.
What evidence suggests that music therapy is effective for improving coping and bonding in high-risk pregnancies?
Research shows that music therapy can help preterm infants manage pain and stress. Studies have found that music eases pain, improves oxygen levels, and stabilizes heart rates in these babies. This calming effect helps them handle the challenges of the neonatal intensive care unit (NICU). In this trial, some participants will receive music therapy sessions before delivery. Although limited research exists on music therapy for pregnant mothers, these findings suggest it might reduce stress and improve bonding. Music therapy could help mothers develop positive coping habits and connect with their babies before birth.35678
Who Is on the Research Team?
Christina Reed, WHNP-BC
Principal Investigator
Baylor College of Medicine
Are You a Good Fit for This Trial?
This trial is for pregnant women aged 18-64 with a high risk of premature delivery, specifically those admitted to the hospital due to preterm premature rupture of membranes. Participants must be willing to listen to music and attend all therapy sessions plus a postpartum follow-up visit.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Music Therapy Intervention
Participants receive four music therapy sessions prior to delivery
Follow-up
Participants are monitored for anxiety, infant bonding, and other outcomes postpartum
What Are the Treatments Tested in This Trial?
Interventions
- Music Therapy Intervention
Music Therapy Intervention is already approved in China, United States for the following indications:
- Anxiety reduction in pregnant women
- Pain relief during labor
- Stress reduction in high-risk pregnancies
- Antepartum-related distress alleviation
- Improved caregiver-infant bonding
- Physiological stress reduction in infants post-partum
Find a Clinic Near You
Who Is Running the Clinical Trial?
Christina Chianis Reed
Lead Sponsor
The Methodist Hospital Research Institute
Collaborator